• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用高灵敏度示差扫描量热法和低温透射电子显微镜对聚乙二醇化脂质体丝裂霉素 C 脂质前药(Promitil)进行表征。

Characterization of Pegylated Liposomal Mitomycin C Lipid-Based Prodrug (Promitil) by High Sensitivity Differential Scanning Calorimetry and Cryogenic Transmission Electron Microscopy.

机构信息

Laboratory of Membrane and Liposome Research, The Hebrew University-Hadassah Medical School, IMRIC , Jerusalem, Israel.

School of Pharmacy, Shanghai Jiao Tong University , Shanghai, China.

出版信息

Mol Pharm. 2017 Dec 4;14(12):4339-4345. doi: 10.1021/acs.molpharmaceut.6b00865. Epub 2017 Oct 30.

DOI:10.1021/acs.molpharmaceut.6b00865
PMID:28045540
Abstract

The effect of a lipidated prodrug of mitomycin C (MLP) on the membrane of a pegylated liposome formulation (PL-MLP), also known as Promitil, was characterized through high-sensitivity differential scanning calorimetry (DSC) and cryo-TEM. The thermodynamic analysis demonstrated that MLP led to the formation of heterogeneous domains in the membrane plane of PL-MLP. MLP concentrated in prodrug-rich domains, arranged in high-ordered crystal-like structures, as suggested by the sharp and high enthalpy endotherm in the first heating scanning. After thiolytic cleavage of mitomycin C from MLP by dithiothreitol (DTT) treatment, the crystal-like prodrug domain disappears and a homogeneous membrane with stronger lipid interactions and higher phase transition temperature compared with the blank (MLP-free) liposomes is observed by DSC. In parallel, the rod-like discoid liposomes and the "kissing liposomes" seen by cryo-TEM in the PL-MLP formulation disappear, and liposome mean size and polydispersity increase after DTT treatment. Both MLP and the residual postcleavage lipophilic moiety of the prodrug increased the rigidity of the liposome membrane as indicated by DSC. These results confirm that MLP is inserted in the PL-MLP liposome membrane via its lipophilic anchor, and its mitomycin C moiety located mainly at the region of the phospholipid glycerol backbone and polar headgroup. We hypothesize that π-π stacking between the planar aromatic rings of the mitomycin C moieties leads to the formation of prodrug-rich domains with highly ordered structure on the PL-MLP liposome membrane. This thermodynamically stable conformation may explain the high stability of the PL-MLP formulation. These results also provide us with an interesting example of the application of high sensitivity DSC in understanding the composition-structure-behavior dynamics of liposomal nanocarriers having a lipid-based drug as pharmaceutical ingredient.

摘要

通过高灵敏度差示扫描量热法(DSC)和冷冻透射电子显微镜(cryo-TEM)研究了米托霉素 C 的脂质前药(MLP)对聚乙二醇化脂质体制剂(PL-MLP)(也称为 Promitil)膜的影响。热力学分析表明,MLP 导致 PL-MLP 膜平面中形成不均匀的域。MLP 集中在富含前药的域中,排列成有序的晶体状结构,正如首次加热扫描中尖锐且高焓的吸热所表明的那样。用二硫苏糖醇(DTT)处理将米托霉素 C 从 MLP 中硫代裂解后,观察到 DSC 中无晶体状前药域,并且与空白(无 MLP)脂质体相比,具有更强脂质相互作用和更高相变温度的均匀膜。同时,在 PL-MLP 制剂中观察到棒状盘状脂质体和“亲吻脂质体”消失,并且 DTT 处理后脂质体平均尺寸和多分散性增加。正如 DSC 所表明的那样,MLP 和前药残留的亲脂部分都增加了脂质体膜的刚性。这些结果证实 MLP 通过其亲脂性锚定插入到 PL-MLP 脂质体膜中,其米托霉素 C 部分主要位于磷脂甘油骨架和极性头部基团的区域。我们假设米托霉素 C 部分的平面芳香环之间的π-π 堆积导致在 PL-MLP 脂质体膜上形成具有高度有序结构的富含前药的域。这种热力学稳定的构象可能解释了 PL-MLP 制剂的高稳定性。这些结果还为我们提供了一个有趣的例子,说明了高灵敏度 DSC 在理解具有基于脂质的药物作为药物成分的脂质体纳米载体的组成-结构-行为动力学方面的应用。

相似文献

1
Characterization of Pegylated Liposomal Mitomycin C Lipid-Based Prodrug (Promitil) by High Sensitivity Differential Scanning Calorimetry and Cryogenic Transmission Electron Microscopy.采用高灵敏度示差扫描量热法和低温透射电子显微镜对聚乙二醇化脂质体丝裂霉素 C 脂质前药(Promitil)进行表征。
Mol Pharm. 2017 Dec 4;14(12):4339-4345. doi: 10.1021/acs.molpharmaceut.6b00865. Epub 2017 Oct 30.
2
Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil(®)): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues.丝裂霉素C聚乙二醇化脂质体前药(Promitil(®))的药理学研究:在血浆中高度稳定,在组织中快速硫解前药活化。
Pharm Res. 2016 Mar;33(3):686-700. doi: 10.1007/s11095-015-1819-7. Epub 2015 Nov 16.
3
Development of Promitil®, a lipidic prodrug of mitomycin c in PEGylated liposomes: From bench to bedside.聚乙二醇化脂质体中丝裂霉素 C 前药 Promitil®的研发:从实验室到临床。
Adv Drug Deliv Rev. 2020;154-155:13-26. doi: 10.1016/j.addr.2020.07.027. Epub 2020 Aug 7.
4
Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.聚乙二醇化脂质体丝裂霉素-C前药对癌细胞叶酸受体的靶向作用:细胞内激活及增强的细胞毒性。
J Control Release. 2016 Mar 10;225:87-95. doi: 10.1016/j.jconrel.2016.01.039. Epub 2016 Jan 22.
5
Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.米托蒽醌脂质体前药的治疗效果:用人胰腺内分泌肿瘤模型的研究。
J Control Release. 2012 Jun 10;160(2):245-53. doi: 10.1016/j.jconrel.2011.11.019. Epub 2011 Nov 26.
6
Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.负载于聚乙二醇化脂质体中的丝裂霉素C脂质前药的毒性降低及治疗活性增强。
Clin Cancer Res. 2006 Mar 15;12(6):1913-20. doi: 10.1158/1078-0432.CCR-05-1547.
7
Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy.用于基于纳米药物的联合化疗的药理学优化的抗癌药物脂质体共包封
Cancer Drug Resist. 2021 Jun 19;4(2):463-484. doi: 10.20517/cdr.2020.87. eCollection 2021.
8
Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients.聚乙二醇化脂质体丝裂霉素C前药增强了丝裂霉素C的耐受性:一项针对晚期实体瘤患者的1期研究。
Cancer Med. 2015 Oct;4(10):1472-83. doi: 10.1002/cam4.491. Epub 2015 Jul 14.
9
Pharmacokinetics of mitomycin-c lipidic prodrug entrapped in liposomes and clinical correlations in metastatic colorectal cancer patients.脂质体包裹的丝裂霉素 C 前药的药代动力学及其在转移性结直肠癌患者中的临床相关性。
Invest New Drugs. 2020 Oct;38(5):1411-1420. doi: 10.1007/s10637-020-00897-3. Epub 2020 Jan 18.
10
Insights into composition/structure/function relationships of Doxil® gained from "high-sensitivity" differential scanning calorimetry.从“高灵敏度”差示扫描量热法获得的关于阿霉素脂质体(Doxil®)组成/结构/功能关系的见解。
Eur J Pharm Biopharm. 2016 Jul;104:260-70. doi: 10.1016/j.ejpb.2016.04.011. Epub 2016 Apr 19.

引用本文的文献

1
Combination therapy with lipid prodrug liposomes reshapes disease-associated neutrophils to promote the cancer-immunity cycle.脂质前药脂质体联合疗法重塑疾病相关中性粒细胞以促进癌症免疫循环。
J Nanobiotechnology. 2025 Feb 22;23(1):132. doi: 10.1186/s12951-025-03179-3.
2
Nano-mupirocin as tumor-targeted antibiotic: Physicochemical, immunotoxicological and pharmacokinetic characterization, and effect on gut microbiome.纳米莫匹罗星作为肿瘤靶向抗生素:物理化学、免疫毒理学和药代动力学特征以及对肠道微生物群的影响。
J Control Release. 2024 Sep;373:713-726. doi: 10.1016/j.jconrel.2024.07.045. Epub 2024 Aug 2.
3
Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy.
用于基于纳米药物的联合化疗的药理学优化的抗癌药物脂质体共包封
Cancer Drug Resist. 2021 Jun 19;4(2):463-484. doi: 10.20517/cdr.2020.87. eCollection 2021.
4
and evaluation of a novel mitomycin nanomicelle delivery system.以及一种新型丝裂霉素纳米胶束递送系统的评估。
RSC Adv. 2019 May 13;9(26):14708-14717. doi: 10.1039/c9ra02660f. eCollection 2019 May 9.
5
Phospholipid prodrug conjugates of insoluble chemotherapeutic agents for ultrasound targeted drug delivery.不溶性化疗药物的磷脂前药缀合物用于超声靶向药物递送。
Nanotheranostics. 2020 Jan 1;4(1):40-56. doi: 10.7150/ntno.37738. eCollection 2020.
6
EphA2-Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAF Mutated Parent- and Vemurafenib-Resistant Melanoma.用于治疗BRAF突变的原发性和维莫非尼耐药性黑色素瘤的EphA2受体靶向聚乙二醇化纳米脂质体
Pharmaceutics. 2019 Oct 1;11(10):504. doi: 10.3390/pharmaceutics11100504.
7
Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy.新型亲脂性 SN38 前药形成稳定的脂质体用于结直肠癌治疗。
Int J Nanomedicine. 2019 Jul 12;14:5201-5213. doi: 10.2147/IJN.S204965. eCollection 2019.